Structural truncation of IL-1R2 enhances the anti-inflammatory activity of HeLa cells
Cell Structure and Function · 2026
DOI: 10.1247/csf.25136 ↗At a glance
Journal article in Cell Structure and Function, 2026. Written by Isao Kato and 8 co-authors. Institution: Division of Applied Oral Sciences, Nihon University Graduate School of Dentistry. Major MEDLINE topics: Receptors, Interleukin-1 Type II. 36 references.
Abstract (original language)
Interleukin-1 receptor type 2 (IL-1R2) functions as a decoy receptor that suppresses IL-1-induced inflammatory signaling. Both membrane-bound IL-1R2 (WT IL-1R2) and its soluble form (sIL-1R2) bind interleukin-1α (IL-1α) at the cell surface or in the extracellular space, thereby inhibiting downstream signaling. However, the anti-inflammatory role of IL-1R2 varies depending on the cellular context and receptor structure. In this study, we generated two IL-1R2 deletion mutants-ΔTM, lacking the transmembrane domain, and ΔTMCP, lacking both the transmembrane and cytoplasmic domains-and compared their functions with those of WT IL-1R2 in HeLa cells. Western blotting, immunoprecipitation, and enzyme-linked immunosorbent assay were used to assess receptor expression, IL-1α binding, and IL-1β-induced interleukin-8 (IL-8) production, respectively. Both ΔTM and ΔTMCP were secreted more efficiently than WT IL-1R2. WT IL-1R2 exhibited weak intracellular interaction with IL-1α, whereas the deletion mutants showed minimal binding. WT IL-1R2 most effectively suppressed IL-1α extracellular release; however, ΔTM and ΔTMCP also reduced secretion. Notably, both deletion mutants suppressed IL-1β-induced IL-8 production more effectively than WT IL-1R2, indicating enhanced extracellular decoy activity. These findings demonstrate that structural modifications of IL-1R2 influence its function as a decoy receptor, and the enhanced inhibitory effects of the deletion mutants on IL-1 signaling provide new insight into the anti-inflammatory potential of soluble IL-1R2 in non-immune cells.Key words: Interleukin-1, Interleukin-1 receptor type 2, decoy receptor, transmembrane, soluble interleukin-1 receptor type 2.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Applied Oral Sciences, Nihon University Graduate School of Dentistry.
- Department of Partial Denture Prosthodontics, Nihon University School of Dentistry.
- Department of Pathology, Nihon University School of Dentistry.
- Division of Immunology and Pathobiology, Dental Research Center, Nihon University School of Dentistry.
- Department of Anatomy, Nihon University School of Dentistry.
- Division of Functional Morphology, Dental Research Center, Nihon University School of Dentistry.
Cite
APA
Kato, I., Hagiwara, Y., Asano, M., Inoue, J., Yamazaki, Y., Yuguchi, M., Yamada, A., Tsunoda, M., & Imaoka, S. (2026). Structural truncation of IL-1R2 enhances the anti-inflammatory activity of HeLa cells. Cell Structure and Function. https://doi.org/10.1247/csf.25136
Vancouver
Kato I, Hagiwara Y, Asano M, Inoue J, Yamazaki Y, Yuguchi M, et al. Structural truncation of IL-1R2 enhances the anti-inflammatory activity of HeLa cells. Cell Structure and Function. 2026. doi:10.1247/csf.25136
BibTeX
@article{Kato2026,
author = {Kato, Isao and Hagiwara, Yoshiyuki and Asano, Masatake and Inoue, Jin and Yamazaki, Yosuke and Yuguchi, Maki and Yamada, Akiko and Tsunoda, Mariko and Imaoka, Saya},
title = {Structural truncation of IL-1R2 enhances the anti-inflammatory activity of HeLa cells},
journal = {Cell Structure and Function},
year = {2026},
doi = {10.1247/csf.25136}
}
EUVIMED